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Squamous cell lung cancerMuscle fructose 1,6-bisphosphate aldolase (ALDA) is a glycolytic enzyme which may localize both in nuclei and
cytoplasm of cells, however its role in the nuclei is unclear. Here, we demonstrate the links between subcellular
localization of ALDA and the cell cycle progression aswell as the availability of energetic substrates. Results of our
studies indicate that nuclear localization of ALDA correlateswith the proliferative activity of the cells andwith the
expression of Ki-67, a marker of proliferation, both in the KLN-205 (mouse lung cancer cells) and human squa-
mous cell lung cancer cells (hSCC). Chemically-induced block of cell cycle entry in S phase and the inhibition
of transcription stimulate removal of ALDA fromcells nuclei suggesting that nuclear ALDA is involved in cells pro-
liferation. On the other hand, subcellular distribution of the enzyme also depends on the stress and pro-survival
signals mediated by the Akt and the p38 pathways and, in non-proliferating cells, on the availability of glucose
and lactate. The results presented here point to ALDA as a factor involved in the regulation of cells proliferation.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Fructose 1,6-bisphosphate aldolase (ALD; EC 4.1.2.13) catalyses the
reversible cleavage of fructose 1,6-bisphosphate to dihydroxyacetone
phosphate and D-glyceraldehyde 3-phosphate [1]. In mammalian tis-
sues, three aldolase isozymes are expressed: ALDA (expressed primarily
inmuscles), aldolase B (mainly expressed in liver) and ALDC (expressed
predominantly in neuronal tissues) [1,2]. However, in most of tissues
the simultaneous expression at least of two isozymes is observed [1,3].
Cancer tissues may express all aldolase isozymes, but ALDA is the
most commonly expressed [4,2,5].
Over the years evidence has accumulated that ALDA with other
glycolytic enzymes may form metabolic complex [6,7] to ensure the
effective ﬂux of intermediates through the glycolysis. Nonetheless, the
nuclear localization of aldolase was also observed in many cells
[8–11,3] and it was shown that aldolase may associate with nucleic
acids [8,12].
Previously, we demonstrated that ALDA localized in nuclei of retinal
proliferating cells [13]. In the present study we demonstrated that
nuclear localization of ALDA in mouse cultured lung cancer cells (the
KLN-205 line) and human squamous cell lung cancer (hSCC) correlated
with the rate of cells proliferation and the nuclear localization of Ki-67,ncer; ALDA, muscle aldolase
colin; ConA, concanavalin A;
tisense oligonucleotide
ights reserved.the protein expressed solely during cell cycle [14–16]. We also show
that down-regulation of ALDA expression with antisense oligonucleo-
tide resulted in the reduction of proliferative activity of cancer cells
and this observation is in line with the latest ﬁndings of Lew and
Tolan [17] who have found that silencing of aldolase expression
inhibited cell proliferation. In the current report we also demonstrated
that blocking of cell cycle progression through S phase and the inhibi-
tion of transcription promoted the removal of ALDA from the nuclei.
On the other hand, we found that in non-proliferating cancer cells, the
subcellular distribution of the enzyme was regulated by energy metab-
olism substrates: glucose, lactate and glutamine.
The results presented in the manuscript suggest that nuclear ALDA
may be involved in a regulation of transcription of genes engaged in
the cell cycle progression.2. Materials and methods
2.1. Chemicals
Polyester wax was from Science Services (Munchen, Germany).
Anti-Ki-67 immunoglobulins (NCL-Ki-67p) and Nunc LockWell™
Maxisorp C8 StarWell plates were from Biokom (Janki, Poland).
Rapamycin and Akt inhibitor IV were obtained from Santa Cruz Bio-
technology Inc. (Santa Cruz, California, USA). Rabbit anti-Akt1/PKB
(phospho S473) antibodies were obtained from Spring Bioscience
(Pleasanton, California, USA). SuperSignal West Pico Chemilumines-
cent Substrate was from Thermo Scientiﬁc. All other reagents were
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grade.
Histologically proven human squamous cell lung cancer (hSCC)
tissue was obtained from Lower Silesian Pulmonary Center (Wroclaw,
Lower Silesia, Poland) in agreement with the rules of the Scientiﬁc
Research Ethical Committee. Rabbit muscle aldolase was puriﬁed
according to Penhoet et al. [1]. Mouse polyclonal antiserum against
muscle aldolase was produced as described previously [11]. The speci-
ﬁcity of the immunoglobulins against aldolasewas conﬁrmed by immu-
noblotting [18] and preabsorption experiments [19] (Supplementary
material; Figs. S1, S2).
2.2. Cell culture
All the cell lines were cultured at 37 °C in a humidiﬁed atmosphere
with 5% CO2 and maintained using standard tissue culture techniques.
Mouse squamous cell carcinoma cell line (the KLN-205) was obtained
from Sigma-Aldrich (Poznan, Poland). The primary culture of explant-
derived human lung cells (the hSCC) was prepared according to Free-
man and Hoffman [20]. Immediately after surgery the histologically
proven Non Small Cell Lung Cancer tumor fragments were put into
Hank's Balanced Salt solution, dissected with scissor into 1 mm3 sec-
tions, and put into culture dishes coated withmatrigel. The primary cul-
tures of NSCLC cells were cultured in Dulbecco'sModiﬁed EagleMedium
(DMEM)with glucose (1 g/L) and sodium pyruvate (0.11 g/L). To avoid
ﬁbroblasts outgrowth of cancer primary cultures, L-valine was
substituted to D-valine (0.094 g/L) [21]. Additionally, the medium
was supplemented with 2 mM glutamine, 1% non-essential amino
acids (NEAA), penicillin (100 U/mL), streptomycin (0.1 mg/mL)
and 10% fetal bovine serum (FBS). For immunoﬂuorescent localiza-
tion of aldolases and Ki-67, explant-derived hSCC cells were
subcultured, by trypsinization, into a new plates without matrigel,
and cultured in DMEMwith L-valine, supplemented with glutamine,
NEAA, FBS and antibiotics (in concentrations described above). In
order to verify the purity of explant-derived hSCC line culture, the
cells were immunostained for cytokeratin-7, a marker of cancer
cells [22] (Supplementary material; Fig. S3).
The KLN-205 cells were cultured in Eagle's Minimum Essential Me-
dium (without sodium pyruvate) supplemented with 2 mMglutamine,
1% non-essential amino acids, penicillin (100 U/mL), streptomycin
(0.1 mg/mL), glucose (1 g/L) and 10% fetal bovine serum (FBS).
The serum starvation experiment as well as aphidicolin (APC)
and concanavalin A (ConA) treatments of the KLN-205 cultures
were performed according to Mamczur et al. [19]. To block the tran-
scriptional activity of cells, the KLN-205 cells were incubated for
20 h with 2.5 μg/mL or 10 μg/mL of actinomycin D as it was de-
scribed by Bensaude [23].
To investigate the effect of energy substrates on ALDA subcellular
distribution in non-proliferating cells, serum deprived the KLN-205
cells (G0 phase cells) were cultured for 20 h in DMEM with L-valine
(0.094 g/L) and sodium pyruvate (0.11 g/L) supplemented with
NEAA, FBS and antibiotics (in concentrations described above) as well
as with glucose (5.5 mM) and/or glutamine (2 mM) and/or lactate
(20 mM).
2.3. Activity measurement
Aldolase activity was assayed spectrophotometrically as described
previously [24], with slight modiﬁcations. One milliliter of the aldolase
assay mixture contained: 1 mM fructose 1,6-bisphosphate, 0.2 mM
NADH, 5 U triose 3-phosphate isomerase, 5 U glycerol 3-phosphate
dehydrogenase in the buffer (50 mM Tris, 0.1 mM ethylenediamine-
tetraacetic acid (EDTA), pH 7.4, 37 °C). One unit of enzyme activity is
deﬁned as the amount of the enzyme that catalyses the formation of
1 μmol of product per minute.To determine aldolase activity inwhole cells homogenates, the KLN-
205 cells were trypsinized, washed with PBS (phosphate-buffered
saline: 137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, 1.5 mM KH2PO4;
pH 7.5, RT) and homogenized in a buffer (50 mM Tris, 250 mM KCl,
1 mM phenylmethylsulfonyl ﬂuoride, 1% Triton X-100, 1 mM EDTA,
1 mM EGTA, 0.014 mg/mL leupeptin; pH 7.4, 4 °C). Then, the homoge-
nate was centrifuged (20 min, 20,000g, 4 °C) and the supernatant was
assayed for the enzyme activity and protein concentration.
Protein concentrations were determined spectrophotometrically
using Bradford Reagent (Sigma-Aldrich, Poznan, Poland), according to
the manufacturer's requirements.
All spectrophotometric measurements were performed with an
Agilent 8453 diode array spectrophotometer. The isolation of nuclei
and cytosol from the KLN-205 cells was performed with CelLytic™
NuCLEAR™ Extraction Kit according to manufacturer's requirements
(Sigma-Aldrich). The determination of glucose 6-phosphate dehydroge-
nase activity (themarker of the cytosolic fraction), and immunoblot for
lamin A (nuclear fraction marker) was performed to conﬁrm the purity
of subcellular fractions (Supplementary material; Table S1, Fig. S4).
2.4. Immunoﬂuorescence
hSCC sections and cultured cells were prepared for immunoﬂu-
orescent studies as describe previously [19], with slight modiﬁca-
tions. The cells and the tissue sections were incubated (overnight,
at 4 °C) with mouse polyclonal anti-aldolase A (1:100) and either
with rabbit polyclonal anti-Ki-67 (1:1000) or rabbit polyclonal
anti-aldolase C (1:100) immunoglobulins, followed by the incuba-
tion (30 min. at RT) with ﬂuorophore-labeled secondary antibod-
ies: goat anti-rabbit-FITC (1:400–1:2000) and goat anti-mouse-
TRITC (1:500–1:2000). For the simultaneous detection of ALDA
and phospho-Akt (pAkt) in the KLN-205, the cells were incubated
with polyclonal rabbit anti-Akt1/PKB (phospho S473) (1:100)
and mouse polyclonal anti-aldolase A (1:100), followed by the
incubation with the secondary antibodies (as above). The tissue
sections and cultures were counterstained with DAPI (0.5 μg/mL,
5 min, RT) to visualize the nuclei. In negative controls, the primary
antibodies were omitted (Supplementarymaterial; Fig. S5). Additional-
ly, in order to check whether the use of different secondary antibodies
may affect aldolase A localization pattern, the cells were stained with
mouse polyclonal anti-aldolase A antibodies (1:100) and either with
goat anti-mouse-FITC (1:1000) or goat anti-mouse-TRITC (1:2000)
secondary antibodies (Supplementary material; Fig. S6).
2.5. Down-regulation of ALDA gene expression
Down-regulation of ALDA expression was performedwith the use
of locked nucleic acid antisense oligonucleotide (LNA-oligo) in the
absence of transfection reagent [25]. The LNA-oligo complementary
to the sequence of mouse ALDA mRNA (GenBank: Y00516.1) was
synthesized and puriﬁed byMetabion International AG (Martinsried,
Germany). This oligonucleotide is the 14-nucleotide long gapmer of the
following sequence: 5′-mCGgtgagcgatgTCm-3′ (capital letters — LNA,
lowercase letters — DNA, m — methylcytosine) and phosphorothioate
internucleoside linkages. To stimulate the decrease of ALDA expression
in the KLN-205 cell culture, the cells were seeded at low density
(1000 cells/cm2) and cultured for 24 h (as described above). Then, the
medium was replaced by DMEM, supplemented with 2 mM glutamine,
penicillin (100 U/mL), streptomycin (0.1 mg/mL), 1% NEAA, 10% FBS
and 5 μM LNA-oligo, and cultured for the next 6 days. The experiment
was performed in the absence and in the presence of glucose (5.5 mM).
2.6. Enzyme-linked immunosorbent assay
Enzyme-linked immunosorbent assay (ELISA) was performed
according to Lukong et al. [26], with modiﬁcations. The protein extracts
2814 P. Mamczur et al. / Biochimica et Biophysica Acta 1833 (2013) 2812–2822from the KLN-205 cells, treated and untreated with LNA-oligo, were
prepared as described previously [19]. ELISA plates were coated (over-
night, at 4 °C) with the cellular extracts (the ﬁnal concentration of pro-
teins was 0.1 μg/mL) in 50 mM sodium bicarbonate buffer (pH 8.2),
and then blocked for 1 h at room temperature with 3% bovine serum
albumin in TTBS buffer: 50 mM Tris, 150 mM NaCl, 0.05% Tween-20
(pH 7.5). Subsequently, ALDA was detected with mouse anti-aldolase A
antibodies (5 μg/mL; overnight at 4 °C). Then, the plate was washed
extensively with TTBS (3 × 10 min), and incubated with goat anti-
mouse antibodies peroxidase-conjugated antibodies (1:30,000; 1 h at
RT). Finally, the plate was washed (as above) and immunoreaction was
visualized with 3,3′,5,5′-tetramethylbenzidine (TMB; 30 min at RT).
The reaction was stopped by 1 M HCl and the absorbance at 450 nm
was readwith the ELISA reader—Asys UVM340 (Biogenet). In control re-
action the primary antibodies were omitted.
2.7. Staining for aldolase activity in polyacrylamide gel
after PAGE separation
The preparation of the tissues and cellular homogenates followed by
the native PAGE and staining for ALD activitywere performed according
to Mamczur and Dzugaj [3].
2.8. Inhibition of protein kinases in the KLN-205 cells
To check which protein kinases may be implicated in the regulation
of subcellular localization of aldolase and Ki-67 in the KLN-205 cells, the
cultures were treated for 20 hwith one of the speciﬁc kinase inhibitors:
KT5720 (PKA inhibitor; 20 μM), DMAT (CKII inhibitor; 10 or 50 μM),
wortmannin (PI3K inhibitor; 1 μM), SB202190 (p38 inhibitor; 50 μM),
rapamycin (mTOR inhibitor; 0.01 μM), Akt inhibitor IV (Akt inhibitor;
1 μM), Myr-RFARKGALRQKNV (PKC inhibitor; 50 μM), SB216763
(GSK3 inhibitor; 10 μM). In some experiments, the cells were treated si-
multaneously with Akt and p38 inhibitors or with lithium chloride
(20 mM), which is a non-selective inhibitor of GSK3 [27]. In order to as-
sure that the culturing conditions did not affect the proteins localiza-
tions and activity, the medium had been changed for the fresh one
24 h before the experiments started. All the inhibitors were diluted in
a fresh medium before being added to the cells.
2.9. Microscopy and statistical analysis
All the sections and the cultures were examined with an Olympus
IX71 ﬂuorescence microscope equipped with Cell^F software (Olympus
Soft Imaging Solutions GmbH) and/or an Olympus FV1000 confocal
microscope. For the evaluation of statistical signiﬁcance a Student's
t-test (GraphPad Software) or one-way ANOVA test (VassarStats)
were used. A probability of p b 0.05 was considered to represent a sig-
niﬁcant difference. The results were expressed as mean and standard
deviation (S.D.). The mitotic index (percentage of mitotic cells) was
determined using DAPI staining of ﬁxed cell cultures [19].
For the confocal microscopy analysis the lasers power (5%)was held
constant during all experiments. Photomultiplier tube (PMT) settings
were in range of 260-450 V, 436-564 V, 423-495 V for DAPI, FITC and
TRITC channels, respectively. Confocal aperture diameter (C.A.) was
set on 110 μm. Kalman averaging was used to reduce the noise in the
images.
To determine the effect of different culturing conditions or agents on
aldolase and Ki-67 nuclear localization, the nuclear/cytoplasmic ratios
of the proteins-related ﬂuorescence were calculated using Cell^F soft-
ware (Olympus Soft Imaging Solutions GmbH).
To measure the mean ﬂuorescence in both cellular compartments,
the nucleus and the cytoplasm of the same cell were marked and the
meanﬂuorescencewithin themarked areaswas counted. Themeasure-
ments were performed for 100-300 individual cells for every studiedcell culturing conditions. The results were veriﬁed in at least three inde-
pendent experiments.
3. Results
3.1. ALD activity in cytosolic and nuclear fractions
ALD subcellular distribution in the KLN-205 cells was preliminary
determined by the measurement of the enzyme activity in the extracts
from subcellular fractions. ALD activity was 0.108 ± 0.039 U/mg of the
total cytosolic proteins and 0.07 ± 0.01 U/mg of the nuclear proteins.
3.2. ALD isoforms expression in the KLN-205 cell line
Native-PAGE separation of proteins extracted from the KLN-205 cells
and variousmouse tissues, followed by staining for aldolase activity dem-
onstrated that mouse skeletal muscles expressed exclusively aldolase A,
whereas mouse brain expressed similar amount of ALDA and ALDC
which formed all possible combinations of homo- and heterotetramers
(Supplementary material; Fig. S7). In mouse liver, aldolase B was the
main enzyme isoform (Supplementary material; Fig. S7) [1].
Our experiment revealed that the KLN-205 cells expressed main-
ly ALDA which formed homotetramers (Supplementary material;
Fig. S7). We also observed that the KLN-205 cells expressed ALDC.
However, the amount of ALDC was many-fold lower than ALDA,
and we could not see any ALDC homotetramers (Supplementary ma-
terial; Fig. S7).
Furthermore, the amount of heteromers containing ALDC was so
small that it was not possible to detect them using antibodies against
ALDA — the results of analysis of native PAGE-separated aldolase from
the KLN-205 cells extract revealed only one band of the mobility corre-
sponding to ALDA homoteramers (Supplementary material; Fig. S7).
From this it is evident, that the presence of small amount of heter-
otetramers should have virtually no effect on statistical analysis of
ALDA subcellular distribution in the KLN-205 cells.
3.3. Coexistence of ALD and Ki-67 in nuclei of cancer cells
Simultaneous immunoﬂuorescent localization of ALDA and Ki-67 in
the KLN-205 cells demonstrated the presence of both the proteins in
cells' nuclei. ALDA co-localized with Ki-67 not only in nucleoplasm but
also in the external part of the nucleoli (Fig. 1A).
Regarding the possibility of the coexistence of ALDA and Ki-67 in a
cell's nuclei, we extended the investigations on hSCC tissue sections
and explant-derived hSCC cells (Fig. 1B, C).
We found that Ki-67 was present in 30% (±6.5) of nuclei in hSCC
sections ((+)Ki-67; Fig. 1C, D). This percentage of Ki-67 positive, prolif-
erating cells is characteristic for lung cancers [28]. About 72% (±4) of
these Ki-67 positive nuclei also contained ALDA ((+)Ki-67(+)ALD;
Fig. 1C, D). Unexpectedly, ALDA was also located in nuclei of 30%
(±7.78) of Ki-67-negative nuclei ((−)Ki-67; referred to G0 phase
cells) (Fig. 1D). Similar correlation between nuclear localization
of ALDA and Ki-67 we observed in explant-derived hSCC cells
(Fig. 1B). In these cells, about 91% (±8.4) of cells positive for nuclear
Ki-67 also contained ALDA in their nuclei.
3.4. The effect of cell culture conﬂuence on ALD subcellular localization
Previously we have demonstrated that increasing density of the
KLN-205 cell culture resulted in the gradual decrease of proliferative
activity which was simultaneous to the decrease of mitotic index and
S/G2/M phase cells [19]. In the current studies we found that these
changes were correlated with the signiﬁcant decrease of nuclear/
cytoplasmic ratio of ALDA-related ﬂuorescence (Fig. 2A, B). In contrast
to ALDA, ALDC heterotetramers were localized mostly in cytoplasm of
the KLN-205 cells and the nuclear/cytoplasmic ratio was practically
Fig. 1. Coexistence of ALDA and Ki-67 in cultured cancer cells and hSCC tissue sections. Ki-67 and ALDA co-localize in the external parts of nucleoli of the KLN-205 cells (A - serial images
through the nucleus (Z-stack) of the KLN-205 cell at 0.45 μm interval) and of the explant-derived hSCC cells (B). Localization of ALDA and Ki-67 in hSCC tissue (C) and the analysis of their
nuclear colocalization (D). Nuclear localization is indicated as (+) and the absence of the protein in nucleus is indicated as (−). Each value represents mean and standard deviation of at
least three independent experiments (p b 0.02). The nuclei were counterstained with DAPI. The scale bars: 7 μm, 90 μm, 60 μm for (A), (B) and (C), respectively.
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pattern of subcellular distribution of both aldolase isozymes was
observed in explant-derived hSCC cells (Supplementary material;
Fig. S8).
This ﬁnding suggested that the presence of ALDC molecule within
aldolase tetramer, composed predominantly or in half from ALDA
molecules, affected themechanism of nuclear transport of the tetramer.
3.5. The effect of serum on ALD and Ki-67 localizations in the KLN-205 cells
The withdrawal of serum from the KLN-205 cells culture causes the
cell cycle exit, which correlates with Ki-67 removing from the nuclei
[19]. In the current studywe showed that serumstarvation also resulted
in ALDA export from the nuclei (Fig. 3A, C). The re-addition of serum to
serum-deprived cells restored nuclear transport of Ki-67 and ALDA
(Fig. 3B). These suggested that some serum-derived extracellular
signals were required for nuclear translocation of ALDA.
3.6. Metabolic intermediates regulates nuclear localization of ALDA
in the KLN-205 at G0 phase
It has been demonstrated that ALDB localizes in nuclei of hepato-
cytes and renal cells, presumably in the manner which correlates with
the metabolic state of cells [9]. Therefore, we tested whether also
ALDA nuclear localization may be affected by energetic metabolites. To
exclude the effect of signaling molecules we incubated the KLN-205
cells in the absence of serum (G0 like phase). In contrast to glucose,
lactate and glutamine stimulated nuclear transport of ALDA (Fig. 4).On the other hand, glucose blocked lactate- and glutamine-stimulated
nuclear accumulation of ALDA.3.7. Protein kinases regulating ALDA and Ki-67 subcellular localization
and aldolase activity
Searching for biological signals whichmay affect ALD nuclear locali-
zation we have tested various inhibitors of several protein kinases.
Among them we found that the inhibition of protein kinase C (PKC)
resulted in the signiﬁcant reduction of nuclear/cytoplasmic ratio of
ALDA and Ki-67 in the KLN-205 cells (Fig. 5A, B, C) with no affect on
aldolase activity (Fig. 5D).
Similar decrease of nuclear/cytoplasmic ratio of ALDA and Ki-67was
observed when Akt activity was inhibited (Fig. 6A, B). However, in con-
trast to PKC, the inhibition of Akt affected (reduced) ALD activity (U/mg
of total cellular proteins) in the cellular extract (Fig. 5D).
As opposed to PKC and Akt, the inhibition of p38 kinase in the KLN-
205 cells stimulated nuclear localization of ALDA and Ki-67 (Fig. 6A, B)
without changes in aldolase activity (Fig. 5D). The simultaneous incuba-
tion of the KLN-205 cells with p38 and Akt inhibitors caused a strong
nuclear accumulation of ALDA and Ki-67 (Fig. 6A, B).
The inhibition of other studied kinases (CKII, PI3K, PKA, mTOR, GSK3)
did not change signiﬁcantly ALD subcellular localization (Fig. 5B),
although the inhibition of two of them (CKII and PI3K) reduced aldolase
activity.
On the other hand, the suppression of the activity ofmost of the above
kinases (CKII, PI3K, PKA, GSK3) decreasedKi-67 nuclear/cytoplasmic ratio
(Fig. 5C).
Fig. 2. The effect of conﬂuence state on ALDA, ALDC and pAkt1 (phospho S473) subcellular distributions in theKLN-205 cells. (A) ALDA localizes both in the cytoplasmand the nuclei of the
KLN-205 cells, whereas ALDC is presentmainly in the cytoplasm. (B) The intensity of nuclear ALD-related immunoﬂuorescent signal changes during the growth of the cell culture. Data are
presented as means and standard deviations of ALDA and ALDC nuclear/cytoplasmic ratio from at least three experiments. (C) Prolonged incubation of the KLN-205 cells to conﬂuence
results in the decrease in the amount of nuclear ALDA and pAkt1 (data not shown). The nuclei were counterstained with DAPI. Scale bar: 90 μm.
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KLN-205 cell proliferation
The effectiveness of ALDA down-regulationwith LNA-oligo, checked
by measurement of the enzyme activity in extracts from the KLN-205
cells revealed about 50% reduction of aldolase activity (Fig. 7A). The de-
crease of ALD activity was similar to the changes of ALDA protein
amount which was diminished by 60% as measured by the ELISA assay
using anti-ALDA-speciﬁc antibodies (Fig. 7B).
The reduction of ALDA abundance resulted in signiﬁcant decrease of
proliferative potential of theKLN-205 cells cultured both in the presence
(Supplementary material; Fig. S9) and in the absence of glucose in the
medium (Fig. 7C–E).3.9. The inﬂuence of concanavalin A, aphidicolin and actinomycin D
on aldolase localization
Concanavalin A (ConA) inhibits cells growth blocking S phase en-
trance throughout the decreasing of the CycD and CycE amounts [29].
The treatment of the KLN-205 cells with ConA resulted in the reduction
of ALDA and Ki-67 nuclear/cytoplasmic ratios by, respectively, 30% and
52% (Fig. 8). Aphidicolin (APC) as a speciﬁc inhibitor of DNApolymerase
α [30] synchronizes cells in S phase [31]. Our results showed that treat-
ment of the KLN-205 cells with APC caused 16% and 22% increase of,
respectively, ALDA and Ki-67 nuclear/cytoplasmic ratio (Fig. 8). The
above results suggested that ADLA might be involved in some nuclear
processes during S phase of cell cycle. Thus, to obtain a deeper insight
Fig. 3.The effect of serumon the localizations of ALDA andKi-67 in theKLN-205 cells. (A) The serumstarvation results in the cell cycle arrestwhich ismanifested by the decrease of nuclear
Ki-67. In such cells ALDA localizes in cytoplasm. (B) After re-addition of serum ALDA and Ki-67 are transported to the nuclei. Cell nuclei were counterstained with DAPI. Scale bar: 40 μm.
(C) The nuclear/cytoplasmic ratio of ALDA-related ﬂuorescencemeasured in the presence (+) and the absence (-) of serum. Bars represent the means and S.D. of at least three individual
experiments.
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ity of cells with actinomycin D [23]. Treatment of the KLN-205 cellswith
this inhibitor reduced the nuclear/cytoplasmic ratio by 45% and 60%
respectively, for aldolase A andKi-67 (Fig. 8) showing that nuclear local-
ization of both the proteinswas dependent on transcriptional activity of
cell and suggesting that ALDA might be involved in the regulation of
expression of genes engaged in cell cycle progression.Fig. 4.The effect of energetic substrates on subcellular localization of ALD inG0 like theKLN-205
counterstained with DAPI. Scale bar: 60 μm. (B) The nuclear/cytoplasmic ratio of ALDA-related
Nuclear/cytoplasmic ratio determined for aldolase in the presence of glucose and in the absenc4. Discussion
Fructose 1,6-bisphosphate aldolase is a cytoplasmic enzyme partici-
pating in glycolysis and gluconeogenesis [32]. However, a growing
body of evidence indicates that a cellular role of aldolase is not restricted
to involvement of the enzyme in carbohydrate metabolism. Nuclear
localization of aldolase [8,9,11,3,13] and its ability to stabilization ofcell line. (A) Immunoﬂuorescent localization of ALDA in theKLN-205 cells. Thenucleiwere
ﬂuorescence. Bars represent themeans and S.D. of at least three individual measurements.
e of lactate and glutamine was assumed to be equal 100%.
Fig. 5. The effect of the inhibition of the signaling kinases on ALDA and Ki-67 subcellular localizations and on the activity of aldolase in extracts from the KLN-205 cells. (A) Immunoﬂu-
orescent localization of ALDA and Ki-67 in the KLN-205 cells. The nuclei were counterstained with DAPI. Scale bar: 90 μm. (B) and (C) The nuclear/cytoplasmic ratio of ALDA- and Ki-67-
related ﬂuorescence. (D) The effect of the inhibition of signaling kinases on ALD activity. Aldolase activity measured in the absence of the inhibitors was assumed to be equal 100%. Each
value represents the mean and S.D. of at least three individual experiments.
2818 P. Mamczur et al. / Biochimica et Biophysica Acta 1833 (2013) 2812–2822transcripts [12] suggests involvement of the enzyme in nuclear process-
es. Nonetheless, the signiﬁcance of the aldolase accumulation in nuclei is
still unclear.
Mouse and human lung cancer cells used in the running study ex-
press both the muscle and the brain aldolase isoforms. As in the case
of cultured retinal glia cells, we found that ALDA, except the cytoplasm,
was localized in cancer cells' nuclei, while ALDC (its heterotetramers
with ALDA) was present only in the cytoplasm [13].Nuclear localization of ALDA was dependent on the density of the
cells' culture. The increase of the density, which correlated with the
reduction of proliferative activity of the KLN-205 cells, resulted in the
removing of ALDA from the nuclei. Additionally, serum deprivation-
stimulated cell cycle exit also promoted the reduction of amount of
nuclear ALDA. The above results suggested that the nuclear localization
of ALDA was correlated with the proliferative activity of the cells. And
indeed, we observed that the inhibition of the cells entry in S phase of
Fig. 6. The effect of Akt and p38 inhibition onALDAand Ki-67 localizations in theKLN-205 cells. (A) The inhibition of Akt causes cytoplasmic retention of ALDAand Ki-67, whereas blocking
of p38 kinase stimulates nuclear accumulation of the proteins even in the presence of Akt inhibitor. Nuclei were counterstainedwith DAPI. Scale bar: 75 μm. (B) The effect of the inhibition
of Akt and p38 on the nuclear/cytoplasmic ratios of ALDA and Ki-67. Each value represents the mean and S.D. of at least three individual experiments.
Fig. 7. The effect of antisense oligonucleotide (LNA-oligo) on ALDA expression and proliferation of the KLN-205 cells in the absence of glucose. (A) The LNA-oligo stimulation resulted in
reduction of aldolase activity in cellular extracts. (B) The decrease of aldolase activity is reﬂected by the reduction of ALDA expression determined using ELISA. (C) Down-regulation of
ALDA correlates with the decrease of proliferative activity of cultured cells and with the reduction of the mitotic index of the KLN-205 cells (D). (E) Density of the KLN-205 cell culture
incubated in the absence of LNA-oligo (−) and in the presence of LNA-oligo (+); the nuclei of the cells were stained with DAPI. Scale bar: 180 μm. Each value represents the mean
and S.D. of at least three individual experiments.
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Fig. 8. The inﬂuence of aphidicolin (APC), actinomycin D (ACD) and convanavalin A (ConA) on ALDA and Ki-67 subcellular distribution in the KLN-205 cells. (A) Immunoﬂuorescent
localization of ALDA and Ki-67 in the cells treated with the APC, ACD and ConA. The nuclei were stained with DAPI. Scale bar: 100 μm. (B) The analysis of ALDA and Ki-67 the nuclear/
cytoplasmic ratios in cultures treated with the APC, ACD and ConA. Each value represents the mean and S.D. of at least three individual experiments.
2820 P. Mamczur et al. / Biochimica et Biophysica Acta 1833 (2013) 2812–2822cell cycle with concanavalin A resulted in ALDAwithdrawal fromnuclei.
Moreover, the synchronization of the cells in S phase with APC affected
in the accumulation of both ALDA and Ki-67, a marker of the prolifera-
tion, in cells' nuclei. This indicates that nuclear localization of ALDA
correlates with DNA replication.
Searching for the role of aldolase in nuclei we found that down-
regulation of ALDA reduced the proliferative activity of cancer cells
both in the presence as well as in the absence of glucose in culture
media. This is in line with the most recent ﬁndings of Lew and Tolan
[17] who have just demonstrated that aldolase A knockdown with
siRNA inhibited proliferation of NIH-3T3 ﬁbroblasts through a non-
glycolytic function, presumably affecting cytokinesis. However, as com-
pared to Lew and Tolan [17] ﬁndings, our studies extended the role of
ALDA in the regulation of the proliferation to the involvement of the
enzyme in nuclear events.
To check if the proliferative-activity-dependent nuclear localization
of aldolase was not constrained only to cell cultures we studied the en-
zyme subcellular distribution in tissue sections of the hSCC. We found
that ALDA co-existed in nuclei of the cancer cells with Ki-67, a marker
of the proliferation, which suggested that proliferative-activity-
dependent nuclear localization of ALDA was a general phenomenon.
Previously we found that aldolase Awas localized in nuclei of proliferat-
ing cells within neonatal retina [13] thus, it might be hypothesized that
nuclear localization of ALDA is not restricted to cancer cells but it is a
common feature of proliferating cells.
However, we also observed aldolase in some of Ki-67-negative
nuclei of the hSCC cells. Ki-67-negative cells are commonly regarded
as cells which have left the cell cycle. Our studies on the localization of
ALDA in the KLN-205 cell line at G0 phase revealed that subcellular lo-
calization of the enzyme depended on the availability of the energetic
substrates. Glucose stimulated cytoplasmic retention of the enzyme,
whereas lactate and glutamine caused nuclear translocation of ALDA.
Thus, the nuclear role of ALD in non-proliferating cells may vary from
that in the proliferating and the subcellular distribution of the enzyme
may be related to the regulation of glycolytic ﬂux: glucose increasesthe amount of ALD molecules in cytoplasm increasing availability of
the enzyme for glycolytic machinery.
The careful examination of subnuclear localization of ALDA and Ki-
67 in the KLN-205 cells revealed the co-localization both of the proteins
in external parts of the nucleoli. The presence of ALDA in nucleoli of
several cell lines has been previously demonstrated [33] however, in
contrast to Ki-67 which is know to play a key role in rRNA synthesis
[34], the function of nucleolar ALDA is yet unknown and requires further
studies.
The hypothesis suggesting the involvement of aldolase in modula-
tion of DNA conformation and/or transcriptional activity of cells was
proposed by Ronai et al. [8]. In the present study we demonstrated
that the inhibition of transcription with actinomycin D promoted the
withdrawal of aldolase and Ki-67 from cancer cells nuclei. This suggests
that ALDAmight be engaged in regulation of cells' proliferation through
modulation of transcription of some, yet unknown, genes involved in
cell cycle progression.
Nuclear localization of ALDA raises a question about themechanism
of the enzyme transport to and out of nuclei and nucleoli. Aldolase does
not contain any known the nuclear and the nucleolar localization sig-
nals (NLS and NoLS, respectively). Thus, it might be presumed that
aldolase is transported to nuclei and nucleoli independently to the
canonical NLS and NoLS and/or that such transport may be regulated
by post-translational modiﬁcations.
Some studies have shown that aldolase may be phosphorylated
in vitro by PKCμ and ERK2 [35,36], but no reports have focused on
the physiological role of these modiﬁcations. In the current survey
we found that the inhibition of Akt (PKB), PKC and p38 (MAPK)
kinases affected both ALDA and Ki-67 nuclear localization in the
KLN-205 cells. Moreover, the inhibition of Akt, PI3K and CKII reduced
the speciﬁc activity of aldolase. On the other hand, nuclear Ki-67-re-
lated ﬂuorescence was dependent also on the activity of: CKII, PKA,
PI3K and GSK3 kinases.
The activation of PI3K/Akt pathway stimulates carbohydrates me-
tabolism, promotes growth, proliferation and survival of several cancer
2821P. Mamczur et al. / Biochimica et Biophysica Acta 1833 (2013) 2812–2822cells [37,38]. We found, that the inhibition of Akt, but not PI3K, reduced
aldolase nuclear/cytoplasmic ratio in the KLN-205 cells. Our study also
revealed that the level of Akt phosphorylation and the amount of
ALDA in nuclei in conﬂuent culture of the KLN-205 cells were reduced
as compared to the low density culture (Fig. 2C). The correlation be-
tween the nuclear localization of ALDA and the abundance of an active,
phosphorylated form of Akt kinase is in linewith our other observations
presented in the manuscript which pointed to nuclear ALDA as a pro-
proliferative factor.
PI3K/Akt signaling pathway may cooperate with PKC kinases which
are frequently involved in promotion of cancerogenesis and proliferation
[39]. Thus, our ﬁnding that PKC inhibition caused the cytoplasmic reten-
tion of ALDA was not unexpected. On the other hand, a promotion of
ALDA nuclear accumulation should have been expected upon blocking
of signals which inhibited cell proliferation. And actually we found that
the inhibition of p38 kinase, which is involved in suppression of tumor
growth and induction of apoptose [40] resulted in nuclear localization
of ALDA.
The mechanism of metabolite-stimulated subcellular localization of
ALDA in G0 like cells is unclear, although its physiological meaning
seems to be obvious — regulation of glycolytic ﬂux. Presumably, just
like in the case of glucokinase [41] nucleus is a reservoir for aldolase
molecules when glucose supply is low.
The presence of ALDA in nuclei of non-proliferating cells suggests,
however, that the nuclear localization of the enzyme is not sufﬁcient
for cells' proliferation and the enzyme plays only auxiliary role in cell
cycle progression. On the other hand, it might be hypothesized that
there are distinct populations of nuclear ALD in silent and proliferating
cells which differ in their posttranslational modiﬁcations, and thus
their physiological role is different.
Our study demonstrates that nuclear localization of aldolase A is cor-
relatedwith the rate of cells' proliferation and that the enzymemight be
involved in the cells' entry to or progression through the S phase of cell
cycle. This apparently resembles the nuclear role of pyruvate kinase
isozyme M2 (PKM2), which may be involved in epidermal growth
factor receptor-dependent cell cycle progression [42] and regulation
of transcription of, for example, glycolytic genes [43]. However, as
opposed to PKM2, aldolase nuclear localization is regulated mainly
by protein kinases (Akt and p38), which activities not only depend
on hormonal signaling, but are also related to metabolic state of a
cell and its environment. Thus, aldolase-related pro-proliferating
signaling might be a part of the basic, primeval mechanism combin-
ing the information on the energetic status and stress signals and the
rate of cells proliferation and/or growth.
Nuclear, non-enzymatic function of glycolytic/gluconeogenic
proteins is not restricted to aldolase and PKM2. It has been shown
that glyceraldehyde-3-phosphate dehydrogenase (GAPDH) plays
many non-enzymatic functions, e.g. transmitting to nucleus infor-
mation on oxidative stress or switching on histone biosynthesis
[44,45], and that fructose 1,6-bisphosphatase is involved in cell
cycle progression [19].
In addition to nuclear function, a line of evidence has been accumu-
lated that enzymes of carbohydrate metabolism display diverse non-
enzymatic activities which are related to a variety of cellular function
within cytoplasm, from the regulation of cytoskeleton stability to regu-
lation of mitochondria function [45–49].
Glycolysis is an evolutionary primal metabolic pathway and it
functions in all groups of organisms on Earth. The ability of glycolytic
enzymes to interact with high energetic molecules, intermediates
and products of cellular metabolism (from nucleotides to free radi-
cals) makes them a main candidates for being sensors and integra-
tors of signals regulating cell fate. Aldolase is one of the most
abundant enzyme within every cell and its tetrahedral conﬁguration
of the heterotetrameric quarternary structure [50] makes aldolase an
excellent binding partner for plurality of cellular proteins. Thus, our
ﬁnding that ALDA is involved in nuclear events, together with thelatest of Lew and Tolan discovery joining aldolase to cell prolifera-
tion, might be the ﬁrst step in unraveling the full range of aldolase
function in a cell.
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